- Home
- PLXS
PLXS
Plexus Corp.
as of 03-11-2026 3:58pm EST
$195.25
+$1.70
+0.88%
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
| Founded: | 1979 | Country: | United States |
| Employees: | 20000 | City: | NEENAH |
| Market Cap: | 5.3B | IPO Year: | 1995 |
| Target Price: | $194.00 | AVG Volume (30 days): | 276.6K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.51 | EPS Growth: | 56.11 |
| 52 Week Low/High: | $103.43 - $211.84 | Next Earning Date: | 04-29-2026 |
| Revenue: | N/A | Revenue Growth: | -4.61% |
| Revenue Growth (this year): | 14.26% | Revenue Growth (next year): | 8.22% |
| P/E Ratio: | 128.12 | Index: | N/A |
| Free Cash Flow: | 154.0M | FCF Growth: | -80.94% |
Stock Insider Trading Activity of Plexus Corp. (PLXS)
Rapp Karen Marie
Sell
Director
PLXS Feb 27, 2026
Avg Cost/Share
$195.59
Shares
500
Total Value
$97,795.00
Owned After
8,535
SEC Form 4
Running Michael J.
Sell
Regional President - AMER
PLXS Feb 25, 2026
Avg Cost/Share
$205.47
Shares
700
Total Value
$143,828.86
Owned After
1,175
SEC Form 4
MARTINEZ RANDY J
Sell
Director
PLXS Feb 25, 2026
Avg Cost/Share
$203.14
Shares
1,000
Total Value
$203,140.10
Owned After
5,201
SEC Form 4
Kelsey Todd P.
Sell
President & CEO
PLXS Feb 18, 2026
Avg Cost/Share
$195.47
Shares
5,231
Total Value
$1,024,111.55
Owned After
83,291
Mihm Oliver K.
Sell
Exec VP & COO
PLXS Feb 18, 2026
Avg Cost/Share
$201.40
Shares
9,541
Total Value
$1,921,557.40
Owned After
12,809
SEC Form 4
Mihm Oliver K.
Sell
Exec VP & COO
PLXS Feb 17, 2026
Avg Cost/Share
$198.79
Shares
2,226
Total Value
$442,495.41
Owned After
12,809
SEC Form 4
Jermain Patrick John
Sell
Exec. VP & CFO
PLXS Feb 12, 2026
Avg Cost/Share
$201.12
Shares
2,321
Total Value
$466,806.25
Owned After
14,561
SEC Form 4
Zycinski Frank
Sell
Regional President - EMEA
PLXS Feb 12, 2026
Avg Cost/Share
$205.99
Shares
1,399
Total Value
$288,183.51
Owned After
0
SEC Form 4
Tan Victor (Pang Hau)
Sell
Regional President - APAC
PLXS Feb 6, 2026
Avg Cost/Share
$205.38
Shares
3,000
Total Value
$616,500.00
Owned After
13,435
FOATE DEAN A
Sell
Director, Other
PLXS Feb 6, 2026
Avg Cost/Share
$205.00
Shares
10,000
Total Value
$2,050,000.00
Owned After
99,429
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Rapp Karen Marie | PLXS | Director | Feb 27, 2026 | Sell | $195.59 | 500 | $97,795.00 | 8,535 | |
| Running Michael J. | PLXS | Regional President - AMER | Feb 25, 2026 | Sell | $205.47 | 700 | $143,828.86 | 1,175 | |
| MARTINEZ RANDY J | PLXS | Director | Feb 25, 2026 | Sell | $203.14 | 1,000 | $203,140.10 | 5,201 | |
| Kelsey Todd P. | PLXS | President & CEO | Feb 18, 2026 | Sell | $195.47 | 5,231 | $1,024,111.55 | 83,291 | |
| Mihm Oliver K. | PLXS | Exec VP & COO | Feb 18, 2026 | Sell | $201.40 | 9,541 | $1,921,557.40 | 12,809 | |
| Mihm Oliver K. | PLXS | Exec VP & COO | Feb 17, 2026 | Sell | $198.79 | 2,226 | $442,495.41 | 12,809 | |
| Jermain Patrick John | PLXS | Exec. VP & CFO | Feb 12, 2026 | Sell | $201.12 | 2,321 | $466,806.25 | 14,561 | |
| Zycinski Frank | PLXS | Regional President - EMEA | Feb 12, 2026 | Sell | $205.99 | 1,399 | $288,183.51 | 0 | |
| Tan Victor (Pang Hau) | PLXS | Regional President - APAC | Feb 6, 2026 | Sell | $205.38 | 3,000 | $616,500.00 | 13,435 | |
| FOATE DEAN A | PLXS | Director, Other | Feb 6, 2026 | Sell | $205.00 | 10,000 | $2,050,000.00 | 99,429 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Jan 28, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYJan 28, 2026 · 100% conf.
AI Prediction BUY
1D
+3.54%
$187.26
Act: +9.26%
5D
+4.61%
$189.18
Act: +8.53%
20D
+10.86%
$200.48
Act: +10.04%
Price: $180.85 Prob +5D: 100% AUC: 1.000
0000785786-26-000005
plxs-202601280000785786false00007857862026-01-282026-01-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 28, 2026
PLEXUS CORP.
(Exact name of registrant as specified in its charter)
Wisconsin001-1442339-1344447 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
One Plexus Way Neenah, Wisconsin 54956 (Address of principal executive offices) (Zip Code) Telephone Number (920) 969-6000 (Registrant’s telephone number, including Area Code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Common Stock, $0.01 par valuePLXSThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On January 28, 2026, Plexus Corp. (“we” or the “Company”) announced results for the fiscal first quarter ended January 3, 2026. A copy of the Company’s related press release is furnished as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits
(d) The following exhibits are filed herewith:
Exhibit NumberDescription 99.1Press release issued by Plexus Corp., dated January 28, 2026
104Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document)
* * * * *
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 28, 2026
PLEXUS CORP.
(Registrant) By: /s/ Patrick J. Jermain
Patrick J. Jermain Executive Vice President and Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Oct 22, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 22, 2025
0000785786-25-000057
plxs-202510220000785786false00007857862025-10-222025-10-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 22, 2025
PLEXUS CORP.
(Exact name of registrant as specified in its charter)
Wisconsin001-1442339-1344447 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
One Plexus Way Neenah, Wisconsin 54957 (Address of principal executive offices) (Zip Code) Telephone Number (920) 969-6000 (Registrant’s telephone number, including Area Code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Common Stock, $0.01 par valuePLXSThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 22, 2025, Plexus Corp. (“we” or the “Company”) announced results for the fiscal fourth quarter and year ended September 27, 2025. A copy of the Company’s related press release is furnished as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits
(d) The following exhibits are filed herewith:
Exhibit NumberDescription 99.1Press release issued by Plexus Corp., dated October 22, 2025
104Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document)
* * * * *
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 22, 2025PLEXUS CORP. (Registrant) By: /s/ Patrick J. Jermain
Patrick J. Jermain Executive Vice President and Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Jul 23, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 23, 2025
0000785786-25-000045
plxs-202507230000785786false00007857862025-07-232025-07-23
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 23, 2025
PLEXUS CORP.
(Exact name of registrant as specified in its charter)
Wisconsin001-1442339-1344447 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
One Plexus Way Neenah, Wisconsin 54957 (Address of principal executive offices) (Zip Code) Telephone Number (920) 969-6000 (Registrant’s telephone number, including Area Code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Common Stock, $0.01 par valuePLXSThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 23, 2025, Plexus Corp. (“we” or the “Company”) announced results for the fiscal third quarter ended June 28, 2025. A copy of the Company’s related press release is furnished as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits
(d) The following exhibits are filed herewith:
Exhibit NumberDescription 99.1Press release issued by Plexus Corp., dated July 23, 2025
104Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document)
* * * * *
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 23, 2025PLEXUS CORP. (Registrant) By: /s/ Patrick J. Jermain
Patrick J. Jermain Executive Vice President and Chief Financial Officer
Latest Plexus Corp. News
PLXS Breaking Stock News: Dive into PLXS Ticker-Specific Updates for Smart Investing
StockStory
Getty Images, Baldwin Insurance Group, Driven Brands, CTS, and Plexus Stocks Trade Down, What You Need To Know
📉
AI Sentiment
Negative
2/10
Compare PLXS vs Leading Stocks
See how PLXS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PLXS Plexus Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.